Latest Additions
Rachel L. Schreiber, MD, from @TeamAllergy discusses #patchtesting for #contactdermatitis.
Sarah Woodrow, MD, of @ClevelandClinic, discusses #neurosurgery and alternative treatment options.
May 6, 2021 | AML Content Hub
AML, acute myeloid leukemia; HR-MDS, high-risk myelodysplastic syndrome; TIM-3, T-cell immunoglobulin and mucin domain-3.
@DermaBlore discusses identification of #latexallergy versus #sanitizer #dermatitis in the #COVID19 #pandemic.
Sunit Kabaria, MD, of @RWJUH, discusses how #COVID19 impacts the #kidneys.
May 2, 2021 | Primary Immunodeficiency Content Hub
Jolan Walter, MD, PhD, of @AllChildrens, discusses #cytopenias and #primaryimmunodeficiency.
@GOssenkoppele discusses #AML treatment in #elderly patients.
May 1, 2021 | Primary Immunodeficiency Content Hub
In an @IDFCommunity Forum, Roger Kobayashi, MD, discusses the importance of #monitoring patients with #primaryimmunodeficiency.
Laura Tushla, MSW, of @RushUniversity discusses #socialsupport for patients with #kidneydisease.
Maryam Rahman, MD, MS, from @UFNeurosurgery, discusses #diagnosis and #treatment of #glioblastoma.